| Hans-Günter Meyer-Thompson | Wechselwirkungen mit Substitutionsmitteln
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021.
Martinez A, Khan T, Dylla DE, Marcinak J, Collins M, Saget B, Conway B.
Harm Reduct J. 2023 Oct 1;20(1):142. doi: 10.1186/s12954-023-00874-y. PMID: 37779203; PMCID: PMC10544489.